REBECCA BARBEE: Open Payments
NPI 1427301027 · DAVIDSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214,277 in 532 payments from 19 companies in 2025. Trend: 2023 $99,306 · 2024 $103,477 · 2025 $214,277
Honoraria: $95,456Speaker / faculty: $59,948Travel & lodging: $27,250Consulting: $22,625Food & beverage: $8,877Education: $121
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 199 | $116,492 |
| Neurocrine BioSciences, Inc. | 109 | $80,018 |
| Alkermes, Inc. | 40 | $13,794 |
| ABBVIE INC. | 13 | $1,298 |
| Otsuka America Pharmaceutical, Inc. | 22 | $522 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $417 |
| Vanda Pharmaceuticals Inc. | 29 | $405 |
| E.R. Squibb & Sons, L.L.C. | 16 | $285 |
| Supernus Pharmaceuticals, Inc. | 14 | $252 |
| Bausch Health US, LLC | 13 | $238 |
Products named: Auvelity, INGREZZA, LYBALVI, ARISTADA, VRAYLAR, CAPLYTA, FANAPT, REXULTI.
Industry payments across NC — which companies pay providers there.
